Skip to main content
Smart Investors Daily
AD

NASDAQ · ADVB

Advanced Biomed Inc. Common Stock

Healthcare · Medical - Diagnostics & Research

$6.38

Up+$0.04 (+0.63%)

Updated Oct 7, 2026, 11:23 AM

SID Score

4.1/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
4.4M
P/E ratio
17.36
Dividend yield
0.00%
52-week range
$3.61 – $24.23
Volume
15.43K
Avg. volume
52.79K

Price performance · ADVB

ADVB price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 6, 2026

ADVB closed at $6.38 after 21 trading sessions, down 28.95% for the selected period.

Last close
$6.38
Period change
-28.95%
Period low
$6.23
Period high
$8.98
Daily close
View OHLC price history
ADVB OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 6, 2026$6.39$6.74$6.38$6.3815.43K
Oct 5, 2026$6.60$7.03$6.34$6.3415.08K
Oct 2, 2026$6.97$7.05$6.50$6.7327.06K
Oct 1, 2026$6.24$7.12$6.24$6.9120.12K
Sep 30, 2026$6.37$6.48$6.23$6.2314.89K
Sep 29, 2026$6.62$6.74$6.31$6.3219.57K
Sep 28, 2026$6.67$7.23$6.59$6.7343.22K
Sep 25, 2026$6.31$6.685$6.31$6.3813.67K
Sep 24, 2026$6.35$6.54$6.31$6.318.88K
Sep 23, 2026$6.41$6.70$6.31$6.3212.35K
Sep 22, 2026$6.53$6.77$6.38$6.3812.4K
Sep 21, 2026$6.61$6.6899$6.28$6.4719.65K
Sep 18, 2026$7.32$7.47$6.26$6.5459.54K
Sep 17, 2026$7.76$8.00$7.232$7.3234.07K
Sep 16, 2026$7.94$8.14$7.72$7.7213.38K
Sep 15, 2026$7.75$8.2096$7.4136$8.0815.24K
Sep 14, 2026$8.21$8.37$7.54$7.7823.98K
Sep 11, 2026$8.87$8.87$7.90$8.1992.2K
Sep 10, 2026$8.29$9.0848$8.29$8.85121.15K
Sep 9, 2026$8.84$9.04$8.38$8.5084.74K
Sep 8, 2026$9.29$9.37$8.65$8.9839.86K

Latest ADVB news

The latest Smart Investors Daily articles mentioning ADVB.

ADVB research

Overview

Company profile and research snapshot.

Company profile

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Jul 24, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers Advanced Biomed (NASDAQ:ADVB) shares moved upwards by 28.3% to $21.53 during Friday's pre-market session. The company's market cap stands at $27.4 million. Akanda (NASDAQ:AKAN) shares increased by

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.